Autopsy report · NCT01573299
Ischemic Stroke and Early Vertical Positioning (SEVEL)
Cause of deathSlow enrollment
“The required number of patients was not reached. The sites were not able to include more patients.Despite several actions the stop of the study has been decided”
Life of this trial
- Registered 5 months after it had already started.
- Ran for about 2 years 9 months before it stopped.
- 167 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Nantes University Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Early Mobilisation in Ischemic Stroke Patients
- Interventions
- Mobilization of stroke patients
- Participants
- 167
- Sites
- 12
- Countries
- France
Trials that died the same way
- Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery
“The study was stopped due to difficulties in including patients” - Midfoot Fusion Bolt (MFB) in the Early Stage of Diabetic-neuropathic Charcot Feet
“The study was stopped because there were not enough eligible patients to complete the study.” - Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy.
“The study was terminated early due to the inability to recruit the planned number of patients” - An Assessment of Voriconazole Pharmacokinetics and Pharmacogenetics in Liver Transplant Recipients - Pilot Study
“Enrolled requested number of patients and completed study. In analysis” - All-On-4® Treatment Concept
“The study stopped as the performance of the study showed insufficient patient recruitment.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.